Ajer Jeffrey Robert 4
4 · NEKTAR THERAPEUTICS · Filed Sep 20, 2023
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
Director
Transactions
- Sale
Common Stock
2023-09-18$0.69/sh−4,359$3,008→ 34,153 total - Award
Stock Option
2023-09-19+85,000→ 85,000 totalExercise: $0.68Exp: 2031-09-18→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction.
- [F2]This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.